SEARCH

SEARCH BY CITATION

References

  • Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArthur J. C., Christov V. I., Dawson T. M. and Dawson V. L. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 19171926.
  • Belmadani A., Zou J., Schipma M. J., Neafsey E. J. and Collins M. A. (2001) Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca (2+)-mediated neurotoxicity. Neuroscience 104, 769781.
  • Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623634.
  • Curthoys N. P. and Watford M. (1995) Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15, 133159.
  • Cutler R. W. and Dudzinski D. S. (1974) Regional changes in amino acid content in developing rat brain. J. Neurochem. 23, 10051009.
  • Droge W., Eck H. P., Betzler M. and Naher H. (1987) Elevated plasma glutamate levels in colorectal carcinoma patients and in patients with acquired immunodeficiency syndrome (AIDS). Immunobiology 174, 473479.
  • Everall I., Heaton R., Markotte T., Ellis R., Cutchan J., Atkinson J., Grant I., Mallory M. and Masliah E. (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocortical disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 9, 209217.
  • Fonnum F. (1984) Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42, 111.
  • Gabuzda D., Wang J. and Gorry P. (2002) HIV-1-associated dementia, in Chemokines and the Nervous System (RansohoffR. M., SuzukiK., ProudfootA. E. I., HickeyW. F. and HarrisonJ. K., eds), pp. 345360. Elsevier Science, Amsterdam.
  • Gelbard H. A., Dzenko K., Diloreto D., Cerro C. D., Cerro M. D. and Epstein L. G. (1993) Neurotoxic effects of tumor necrosis factor in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtypes: implications for AIDS neuropathogenesis. Dev. Neurosci. 15, 417422.
  • Gelbard H., Nottet H., Dzenko K. et al. (1994) Platelet-activating factor: a candidate human immunodeficiency virus type-1 infection neurotoxin. J. Virol. 68, 46284635.
  • Gendelman H. E. (1997) The neuropathogenesis of HIV-1-dementia, in The Neurology of AIDS (GendelmanH. E., LiptonS. A., EpsteinL. G. and SwindellsS., ed.), pp. 110. Chapman & Hall, New York.
  • Genis P., Jett M., Bernton E. et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage–astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 17031718.
  • Giulian D., Wendt E., Vaca K. and Noonan C. A. (1993) The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl Acad. Sci. USA 90, 27692773.
  • Giulian D., Yu J., Xia L., Tom D., Li J., Lin S. N., Schwarz R. and Noonan C. (1996) Study of receptor-mediated neurotoxins released by HIV-1 infected mononuclear phagocytes found in human brain. J. Neurosci. 16, 31393153.
  • Glass J. D., Fedor H., Wesselingh S. L. and McArthur J. C. (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38, 755762.
  • Hagberg H., Lehmann A., Sandberg M., Nystrom B., Jacobson I. and Hamberger A. (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J. Cereb. Blood Flow Metab. 5, 413419.
  • Heyes M. P., Brew B. B., Martin A. et al. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29, 202209.
  • Holcomb T., Taylor L., Trohkimoinen J. and Curthoys N. P. (2000) Isolation, characterization and expression of a human brain mitochondrial glutaminase cDNA. Brain Res. Mol. Brain Res. 76, 5663.
  • Jiang Z., Piggee C., Heyes M. P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H. E. and Markey S. P. (2001) Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117, 97107.
  • Koenig S., Gendelman H. E., Orenstein J. M., Canto M. C. D., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A. and Fauci A. S. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 10891093.
  • Kovacs D. M., Mancini R., Henderson J., Na S. J., Schmidt S. D., Kim T. W. and Tanzi R. E. (1999) Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells. J. Neurochem. 73, 22782285.
  • Kvamme E., Svenneby G., Hertz L. and Schousboe A. (1982) Properties of phosphate activated glutaminase in astrocytes cultured from mouse brain. Neurochem. Res. 7, 761770.
  • Lipton S. A. and Gendelman H. E. (1995) Dementia associated with the acquired immunodeficiency syndrome. New Engl. J. Med. 16, 934940.
  • McCall A., Glaeser B. S., Millington W. and Wurtman R. J. (1979) Monosodium glutamate neurotoxicity, hyperosmolarity, and blood–brain barrier dysfunction. Neurobehav. Toxicol. 1, 279283.
  • Mollace V., Nottet H. S., Clayette P., Turco M. C., Muscoli C., Salvemini D. and Perno C. F. (2001) Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24, 411416.
  • Moses A. V., Bloom F. E., Pauza C. D. and Nelson J. A. (1993) HIV infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl Acad. Sci. USA 90, 1047410478.
  • Nath A. and Geiger J. (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54, 1933.
  • Nath A., Hartloper V., Furer M. and Fowke K. R. (1995) Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. J. Neuropathol. Exp. Neurol. 54, 320330.
  • Navia B. A., Dafni U., Simpson D., Tucker T., Singer E., McArthur J. C., Yiannoutsos C., Zaborski L. and Lipton S. A. (1998) A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 51, 221228.
  • Newcomb R., Sun X., Taylor L., Curthoys N. and Epsfard R. G. (1997) Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death. J. Biol. Chem. 272, 1127611282.
  • Nicklas W. J., Zeevalk G. and Hyndman A. (1987) Interactions between neurons and glia in glutamate/glutamine compartmentation. Biochem. Soc. Trans. 15, 208210.
  • Ollenschlager G., Jansen S., Schindler J., Rasokat H., Schrappe-Bacher M. and Roth E. (1988) Plasma amino acid pattern of patients with HIV infection. Clin. Chem. 34, 17871789.
  • Olney J. W. (1971) Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J. Neuropathol. Exp. Neurol. 30, 7590.
  • Orrego F. and Villanueva S. (1993) The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization. Neuroscience 56, 539555.
  • Power C., McArthur J. C., Nath A., Wehrly K., Mayne M., Nishio J., Langelier T., Johnson R. T. and Chesebro B. (1998) Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol. 72, 90459053.
  • Pulliam L., Clarke J. A., McGuire D. and McGrath M. S. (1994) Investigation of HIV-infected macrophage neurotoxin production from patients with AIDS dementia. Adv. Neuroimmunol. 4, 195198.
  • Rostasy K., Monti L., Yiannoutsos C., Wu J., Bell J., Hedreen J. and Navia B. A. (2000) NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex. J. Neurovirol. 6, 537543.
  • Strizki J. M., Albright A. V., Sheng H., O'Connor M., Perrin L. and Gonzalez-Scarano F. (1996) Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism. J. Virol. 70, 76547662.
  • Tornatore C., Nath A., Amemiya K. and Major E. O. (1991) Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65, 60946100.
  • Tossman U., Segovia J. and Ungerstedt U. (1986) Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydophamine-lesioned rats measured with microdialysis. Acta Physiol. Scand. 127, 547551.
  • Ward H. K., Thanki C. M. and Bradford H. F. (1983) Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies. J. Neurochem. 40, 855860.
  • Wiley C. A. (1995) Quantitative neuropathologic assessment of HIV-1 encephalitis. Curr. Top. Microbiol. Immunol. 202, 5561.
  • Wurdig S. and Kugler P. (1991) Histochemistry of glutamate metabolizing enzymes in the rat cerebellar cortex. Neurosci. Lett. 130, 165168.
  • Zheng J., Thylin M. R., Cotter R. L., Lopez A. L., Ghorpade A., Persidsky Y., Xiong H., Leisman G. B., Che M. H. and Gendelman H. E. (2001a) HIV-1 infected and immune competent mononuclear phagocytes induce quantitative alterations in neuronal dendritic arbor: relevance for HIV-1-associated dementia. Neurotox. Res. 3, 443459.
  • Zheng J., Thylin M. R., Persidsky Y., Williams C. E., Cotter R. L., Zink W., Ryan L., Ghorpade A., Lewis K. and Gendelman H. E. (2001b) HIV-1 infected immune competent mononuclear phagocytes influence the pathways to neuronal demise. Neurotox. Res. 3, 461484.
  • Zink W. E., Zheng J., Persidsky Y., Poluektova L. and Gendelman H. E. (1999) The neuropathogenesis of HIV-1 infection. FEMS Immunol. Med. Microbiol. 26, 233241.